Profiles: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
==See Also== | ==See Also== | ||
*[[How to use QIBA Profiles]] | *[[How to use QIBA Profiles]] | ||
*[[Committees|Biomarker | *[[Committees|Biomarker Committee]] pages may also have links to DRAFT Profile documents for the next Stage. | ||
*[[Profile Conformance]] describes how sites and products claim conformance to a Profile. | *[[Profile Conformance]] describes how sites and products claim conformance to a Profile. | ||
*[[QIBA Profile Template]] shows the structure, rationale and content of a Profile (''show "All Markup" to see guidance in the Word comments'') | *[[QIBA Profile Template]] shows the structure, rationale and content of a Profile (''show "All Markup" to see guidance in the Word comments'') | ||
*[[Work Product for Review]] | *[[Work Product for Review]] | ||
Revision as of 01:07, 18 February 2017
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed Profiles
Stage 2: Consensus Profiles
Stage 1: Public Comment Profiles
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
Statements of Endorsement
See Also
- How to use QIBA Profiles
- Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.
- QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)